Personality and differential treatment response in major depression: A randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy

Canadian Journal of Psychiatry

Volumn 53, Issue 6, 2008, Pages 361-370

  Bagby, R Michael ^a,b   Quilty, Lena C ^a,b   Segal, Zindel V ^a,b   McBride, Carolina C ^a,b   Kennedy, Sidney H ^b,c   Costa Jr , Paul T ^d,e  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Depression; Personality; Pharmacotherapy; Psychotherapy; Treatment selection

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; PAROXETINE; PHENELZINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONSCIENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTRAVERSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROSIS; PATIENT ASSESSMENT; PERSONALITY; PERSONALITY TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; TRUST;

EID: 45849141256     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805300605     Document Type: Article

References (64)

1. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157.
2. Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments. Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry. 2001;46:1S-92S.
3. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psychological Science in the Public Interest. 2002;3:39-77.
4. Judd LL, Paulus MP, Zeller P. The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Arch Gen Psychiatry. 1999;56:764 -765.
5. Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005;66:974 -981.
6. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28-40.
7. Thase ME. How should efficacy be evaluated in randomized clinical trials of treatments for depression? J Clin Psychiatry. 1999;60:23-31.
8. Mattocks KM, Horwitz RI. Placebos, active control groups, and the unpredictability paradox. Biol Psychiatry. 2000;47:693- 698.
9. Kennedy SH, Farvolden P, Cohen NL, et al. The impact of personality on the pharmacological treatment of depression. In: Rosenbluth M, Kennedy SH, Bagby RM, editors. Depression and personality: conceptual and clinical challenges. Washington (DC): American Psychiatric Publishing; 2005. p 97-119.
10. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002;159:359-371.
11. Costa PT, McCrae RR. Revised NEO personality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Odessa (FL): Psychological Assessment Resources; 1992.
12. Kool S, Schoevers R, de Maat S, et al. Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. J Affect Disord. 2005;88:269-278.
13. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry. 2006;88:13-20.
14. Eysenck HJ, Eysenck SB. Manual of the Eysenck personality inventory. London (GB): University of London; 1964.
15. Eysenck HJ. Manual of the Maudsley personality inventory. London (GB): University of London Press; 1959.
16. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-989.
17. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573-588.
18. Costa PT, McCrae RR. The NEO personality inventory manual. Odessa (FL): Psychological Assessment Resources; 1985.
19. Harkness AR, McNulty JL. The personality psychopathology five (PSY-5): issues from the pages of a diagnostic manual instead of a dictionary. In: Strack S, Lorr M, editors. Differentiating normal and abnormal personality. New York (NY): Springer Publishing Co; 1994. p 291-315.
20. Bagby RM, Joffe RT, Parker JDA, et al. Major depression and the five-factor model of personality. J Personal Disord. 1995;9:224-234.
21. Du L, Bakish D, Ravindran AV, et al. Does fluoxetine influence major depression by modifying five-factor personality traits? J Affect Disord. 2002;71:235-241.
22. Petersen T, Papakostas GI, Bottonari K, et al. NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Res. 2002;109:9-16.
23. Elkin I, Shea MT, Watkins JT, et al. National institute of mental health treatment of depression collaborative research program: general effectiveness of treatments. Arch Gen Psychiatry. 1989;46:971-982.
24. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1991;148:997-1008.
25. Weissman AN, Beck AT. Developmental validation of the dysfunctional attitude scale. Paper presented at the Annual Meeting of the Association of Advancement of Behavioral Therapy. Chicago (IL): 1978.
26. Blatt SJ, Quinlan DM, Pilkonis PA, et al. Impact of perfectionism and need for approval on the brief treatment of depression: the national institute of mental health treatment of depression collaborative research program revisited. J Consult Clin Psychol. 1995;63:125-132.
27. Blatt SJ, Zuroff DC, Bondi CM, et al. When and how perfectionism impedes the brief treatment of depression: further analyses of the national institute of mental health treatment of depression collaborative research program. J Consult Clin Psychol. 1998;66:423-428.
28. Rector NA, Bagby RM, Segal ZV, et al. Self-criticism and dependency in depressed patients treated with cognitive therapy or pharmacotherapy. Cognit Ther Res. 2000;24:571-584.
29. Blatt SJ, D'Affitti JP, Quinlan DM. Experiences of depression in normal young adults. J Abnorm Psychol. 1976;85:383-389.
30. McBride C, Atkinson L, Quilty LC, et al. Attachment as moderator of treatment outcome in major depression: a randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. J Consult Clin Psychol. 2006;74:1041-1054.
31. Griffin DW, Bartholomew K. The metaphysics of measurement: the case of adult attachment. In: Bartholomew K, Perlman D, editors. Advances in personal relationships: attachment processes in adulthood. London (GB): Jessica Kingsley; 1994. p 17-52.
32. Joyce PR, McKenzie JM, Carter JD, et al. Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry. 2007;190:503-508.
33. First MB, Gibbon M, Spitzer RL, et al. User's guide for the structured clinical interview for DSM-IV Axis II personality disorders. Washington (DC): American Psychiatric Press; 1997.
34. Cohen J. A power primer. Psych Bull. 1992;112:155-159.
35. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV Axis I disorders - patient edition (version 2). New York (NY): Biometric Research Institute; 1995.
36. Hamilton M. Development of a rating scale for primary depressive illness. J Clin Psychol. 1967;6:278-296.
37. Bagby RM, Ryder AG, Schuller DR, et al. The Hamilton depressive rating scale: have the gold standard become a lead weight? Am J Psychiatry. 2004;161:2163-2177.
38. Ebstein RP. The molecular genetic architecture of human personality: beyond self-report questionnaires. Mol Psychiatry. 2006;11:427-445.
39. Levinson DF. The genetics of depression: a review. Bio Psychiatry. 2006;60:84-92.
40. McCrae RR, Allik J. The five-factor model across cultures. New York (NY): Kluwer-Plenum; 2002.
41. McCrae RR, Terracciano A. Universal features of personality traits from the observer's perspective: data from 50 cultures. J Pers Soc Psychol. 2005;88:547-561.
42. Bagby RM, Bindseil KD, Schuller DR, et al. Relationship between the five-factor model of personality and unipolar, bipolar, and schizophrenic patients. Psychiatry Res. 1997;70:83-94.
43. Bagby RM, Levitan RD, Kennedy SH, et al. Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity. Psychiatry Res. 1999;86:211-216.
44. Costa PT, Bagby RM, Herbst JH, et al. Personality self-reports are concurrently reliable and valid during acute depressive episodes. J Affect Disord. 2005;89:45-55.
45. Greenberger D, Padesky CA. Mind over mood: a cognitive therapy treatment manual for clients. New York (NY): Guilford Press; 1995.
46. Beck AT, Rush AJ, Shaw BF, et al. Cognitive therapy of depression. New York (NY): Guilford Press; 1979.
47. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry. 1991;48:851-855.
48. Knutson B, Wolkowitz OM, Cole SW, et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998;115:373-379.
49. Gaynes BN, Davis L, Rush AJ, et al. The aims and design of the sequenced treatment alternative to relieve depression (STAR*D) study. Prim Psychiatry. 2005;12:36-41.
50. Vittengl JR, Clark LA, Dunn TW, et al. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol. 2007;75:475-488.
51. Horvath AO, Bedi RP. The alliance in psychotherapy relationships that work: therapist contributions and responsiveness to patients. Norcross JC, editor. New York (NY): Oxford University Press; 2002.
52. Waddington L. The therapy relationship in cognitive therapy: a review. Behav Cogn Psychother. 2002;30:179-192.
53. Trull TJ, Durrett CA. Categorical and dimensional models of personality disorder. Annu Rev Clin Psychol. 2005;1:355-380.
54. Livesley WJ, Jang KL, Vernon PA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry. 1998;55:941-948.
55. Widiger TA. Four out of five ain't bad. Arch Gen Psychiatry. 1998;55:865-866.
56. McCrae RR, Costa RT. Conceptions and correlates of openness to experience. In: Hogan R, Johnson JA, Briggs SR, editors. Handbook of personality psychology. San Diego (CA): Academic Press; 1997. p 825-847.
57. O'Connor BP. A search for consensus on the dimensional structure of personality disorders. J Clin Psychol. 2005;61:323-345.
58. Lynam DR, Widiger TA. Using the five-factor model to represent the DSM-IV personality disorders: an expert consensus approach. J Abnorm Psychol. 2001;110:401-412.
59. Miller JD, Pilkonis PA, Morse JO. Five-factor model prototypes for personality disorders: the utility of self-reports and observer ratings. Assessment. 2004;11:127-138.
60. Trull TJ, Widiger TA, Useda JD, et al. A structured interview for the assessment of the five-factor model of personality. Psychol Assess. 1998;10:229-240.
61. Bagby RM, Costa PT, Widiger TA, et al. DSM-IV personality disorders and the five-factor model of personality: a multi-method examination of domain - and facet-level predictions. Eur J Pers. 2005;19:307-324.
62. Bagby RM, Rector NA, Bindsel K, et al. Self-report ratings and informants' ratings of personalities of depressed outpatients. Am J Psychiatry. 1998;155:437-438.
63. Heinz A, Jones DW, Mazzanti C, et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Bio Psychiatry. 2000;47:643-649.
64. Lesch K, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.